fda warning letters compounded semaglutide october 2025 warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain FDA Drug Recalls and Warnings:

Factors affecting in-body duration: Renal function: Individuals with impaired renal function may experience altered drug exposure

However, that doesnt mean its right for everyone

Retatrutide is still being evaluated in Phase 3 clinical trials

Factual situation as of May 2026, with associated HAS and ANSM data

Additionally, SGLT2i can lower HbA1c levels by 0.5-1.0% and support weight loss ( Studies have indicated that increased expression of the sodium-hydrogen exchanger isoform 1 (NHE-1) is linked to heart failure and may contribute to the development of hypertrophy and cardiac injury during ischemia and reperfusion ( Of note, long-term use of SGLT2i may lead to a reduction in glycosuric efficacy, without a corresponding decline in cardiovascular benefits

\No Worsening of Insulin Sensitivity: Does not appear to negatively impact blood sugar control, even with increased growth hormone activity